無料レポート プレゼントキャンペーン 実施中 : メールサービスに新規登録いただいた方にご用意した無料レポートをご提供

株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

世界の埋め込み型ドラッグデリバリーデバイス市場 - 製品タイプ、技術、用途、地域別 - 成長率、市場動向、市場予測(2018年〜2023年)

Global Implantable Drug Delivery Devices Market - Segmented by Product Type, Technology, Application, Geography - Growth, Trends, and Forecasts (2018 - 2023)

発行 Mordor Intelligence LLP 商品コード 707340
出版日 ページ情報 英文 114 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=114.67円で換算しております。
Back to Top
世界の埋め込み型ドラッグデリバリーデバイス市場 - 製品タイプ、技術、用途、地域別 - 成長率、市場動向、市場予測(2018年〜2023年) Global Implantable Drug Delivery Devices Market - Segmented by Product Type, Technology, Application, Geography - Growth, Trends, and Forecasts (2018 - 2023)
出版日: 2018年08月01日 ページ情報: 英文 114 Pages
概要

世界の埋め込み型ドラッグデリバリーデバイス市場は、2018年から2023年にかけて、7.8%のCAGRで推移することが予測されています。ゲノミクス、プロテオミクス、バイオテクノロジー分野の技術発展と新薬の登場によって、埋め込み型ドラッグデリバリーデバイス市場の成長が促進されています。

当レポートでは、世界の埋め込み型ドラッグデリバリーデバイス市場を調査し、市場の概要、製品タイプ・技術・用途・地域別の市場規模の推移と予測、市場動向、市場規模の推移と予測、市場の成長要因および阻害要因の分析、市場機会、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 イントロダクション

  • 市場の定義

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 主な影響要因

第5章 埋め込み型ドラッグデリバリーデバイス市場の概要

  • 現在の市場シナリオ
  • ファイブフォース分析
    • 買い手の交渉力
    • 供給企業の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係

第6章 市場力学

  • 成長要因
    • 低侵襲手術のニーズの高まり
    • 新製品の登場
    • 慢性疾患の有病率の上昇
  • 阻害要因
    • デバイスのコストの高さ
    • 厳格な規制シナリオ
  • 市場機会
  • 主な課題

第7章 埋め込み型ドラッグデリバリーデバイス市場:セグメント別

  • 製品タイプ別
    • 薬物注入ポンプ
    • 眼内ドラッグデリバリーデバイス
    • 避妊ドラッグデリバリーデバイス
    • ステント
  • 技術別
    • 生分解性インプラント
    • 非生分解性インプラント
  • 用途別
    • 腫瘍学
    • 心血管
    • 自己免疫疾患
    • 産婦人科
    • その他
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東・アフリカ
    • 南米

第8章 企業プロファイルと競合情勢

  • Abbott
  • Allergan
  • Boston Scientific Corporation
  • Bausch and Lomb Inc.
  • Delpor Inc.
  • Medtronic
  • Novartis
  • pSivida Corp.
  • Teleflex Incorporated
  • 3M's Health Care

第9章 市場の将来展望

目次
Product Code: 62809

The implantable drug delivery devices market is expected to grow at a CAGR of 7.8%. The implantable drug delivery devices market is expected to witness a robust growth due to the recent developments taking place in genomics, proteomics and biotechnology that have led to emerging classes of novel pharmaceutical compounds across the globe that helps to accelerate the market. These implantable devices are gaining edge over conventional oral due to site specific and sustained release therapeutic action of implantable devices, which further minimizes the side-effects associated with the drug.

Increasing Prevalence of Chronic Diseases Boosts the Growth of Implantable Drug Delivery Devices Market

According to World Health Organization (WHO) 2017, chronic diseases are the major cause of disabilities worldwide. The estimated global burden by 2020 is 60% and moreover, 73% of deaths in 2020 is expected to be due to chronic diseases. The burden of chronic diseases is increasing rapidly. The proportion of the burden of the chronic diseases is expected to increase by 57% by 2020. Almost half of the total chronic disease deaths are attributable to cardiovascular diseases; obesity and diabetes and are found to affect a large proportion of the population. Thus the increase in burden of chronic disesaes is affecting the large patient population which increases the number of surgeries and hence drives the implantable drug delivery devices market.

The other driving factors also includes increasing demand for minimally invasive procedures and emergence of novel products.

High Cost of Devices to Restrain the Growth of Implantable Drug Delivery Devices Market

The substantial costs arise at the time of surgical implantation, as well as at the time of revision for expenditure of the devices for the catheter displacement, device malfunction or infection that requires surgical explantation or revision. Hence due to the substantial amount of high cost of devices and surgery costs, the adoption rate is less which is restraining the growth of implantable drug delivery devices market.

The other factors also includes stringent regulatory scenario.

North America Dominates the Implantable Drug Delivery Devices Market

North America is expected to dominate the implantable drug delivery devices market owing to new product launches in this region. Asia Pacific region is also anticipated to grow, attributed to the steadily growing healthcare spending as well as awareness levels of implantable drug delivery devices. The regulatory policies and healthcare infrastructure quality are further anticipated to broaden the scope for growth in this region.

Key Developments in the Implantable Drug Delivery Devices Market:

Jan 2018: Medtronic Plc has received FDA approval of a new clinician programmer for use with the SynchroMed(TM) II Intrathecal Drug Delivery system, an implantable pump that provides targeted drug delivery for chronic pain and severe spasticity.

Oct 2016: Teleflex signs a new agreement with Premier for implantable infusion ports. The agreement begins November 1, 2016, and extends through October 31, 2019.

Implantable Drug Delivery Devices Market Major Players: Boston Scientific Corporation, Bausch and Lomb Inc., Delpor Inc., Medtronic, pSivida Corp. and Teleflex Incorporated among others.

Reasons to Purchase the Implantable Drug Delivery Devices Market Report:

Current and future global implantable drug delivery devices market outlook in the developed and emerging markets

Analyzing various perspectives of the market with the help of Porter's five forces analysis

The segment that is expected to dominate the market

Regions that are expected to witness fastest growth during the forecast period

Identify the latest developments, market shares and strategies employed by the major market players

3-month analyst support along with the Market Estimate sheet (in Excel)

Customization of the Implantable Drug Delivery Devices Market Report:

This report can be customized to meet your requirements. Please connect with our representative who will ensure you get a report that suits your needs.

Table of Contents

1. Introduction

  • 1.1 Market Definition

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Implantable Drug Delivery Devices Market Overview

  • 5.1 Current Market Scenario
  • 5.2 Porter's Five Forces Analysis
    • 5.2.1 Bargaining Power of Suppliers
    • 5.2.2 Bargaining Power of Consumers
    • 5.2.3 Threat of New Entrants
    • 5.2.4 Threat of Substitute Product and Services
    • 5.2.5 Competitive Rivalry within the Industry

6. Implantable Drug Delivery Devices Market Dynamics

  • 6.1 Drivers
    • 6.1.1 Increasing Demand for Minimally Invasive Procedures
    • 6.1.2 Emergence of Novel Products
    • 6.1.3 Increasing Prevalence of Chronic Diseases
  • 6.2 Restraints
    • 6.2.1 High Cost of Devices
    • 6.2.2 Stringent Regulatory Scenario
  • 6.3 Opportunities
  • 6.4 Key Challenges

7. Implantable Drug Delivery Devices Market Segmentation

  • 7.1 By Product Type
    • 7.1.1 Drug Infusion Pumps
    • 7.1.2 Intraocular Drug Delivery Devices
    • 7.1.3 Contraceptive Drug Delivery Devices
    • 7.1.4 Stents
  • 7.2 By Technology
    • 7.2.1 Biodegradable Implants
    • 7.2.2 Non-Biodegradable Implants
  • 7.3 By Application
    • 7.3.1 Oncology
    • 7.3.2 Cardiovascular
    • 7.3.3 Autoimmune Diseases
    • 7.3.4 Obstetrics and Gynecology
    • 7.3.5 Others
  • 7.4 By Geography
    • 7.4.1 North America Implantable Drug Delivery Devices Market (2018-2023)
      • 7.4.1.1 United States Implantable Drug Delivery Devices Market (2018-2023)
      • 7.4.1.2 Canada Implantable Drug Delivery Devices Market (2018-2023)
      • 7.4.1.3 Mexico Implantable Drug Delivery Devices Market (2018-2023)
    • 7.4.2 Europe Implantable Drug Delivery Devices Market (2018-2023)
      • 7.4.2.1 France Implantable Drug Delivery Devices Market (2018-2023)
      • 7.4.2.2 Germany Implantable Drug Delivery Devices Market (2018-2023)
      • 7.4.2.3 United Kingdom Implantable Drug Delivery Devices Market (2018-2023)
      • 7.4.2.4 Italy Implantable Drug Delivery Devices Market (2018-2023)
      • 7.4.2.5 Spain Implantable Drug Delivery Devices Market (2018-2023)
      • 7.4.2.6 Rest of Europe
    • 7.4.3 Asia-Pacific Implantable Drug Delivery Devices Market (2018-2023)
      • 7.4.3.1 China Implantable Drug Delivery Devices Market (2018-2023)
      • 7.4.3.2 Japan Implantable Drug Delivery Devices Market (2018-2023)
      • 7.4.3.3 India Implantable Drug Delivery Devices Market (2018-2023)
      • 7.4.3.4 Australia Implantable Drug Delivery Devices Market (2018-2023)
      • 7.4.3.5 South Korea Implantable Drug Delivery Devices Market (2018-2023)
      • 7.4.3.6 Rest of Asia-Pacific
    • 7.4.4 Middle East & Africa Implantable Drug Delivery Devices Market (2018-2023)
      • 7.4.4.1 GCC Implantable Drug Delivery Devices Market (2018-2023)
      • 7.4.4.2 South Africa Implantable Drug Delivery Devices Market (2018-2023)
      • 7.4.4.3 Rest of the Middle East & Africa
    • 7.4.5 South America Implantable Drug Delivery Devices Market (2018-2023)
      • 7.4.5.1 Brazil Implantable Drug Delivery Devices Market (2018-2023)
      • 7.4.5.2 Argentina Implantable Drug Delivery Devices Market (2018-2023)
      • 7.4.5.3 Rest of South America

8. Company Profiles & Competitive Landscape

  • 8.1 Abbott
  • 8.2 Allergan
  • 8.3 Boston Scientific Corporation
  • 8.4 Bausch and Lomb Inc.
  • 8.5 Delpor Inc.
  • 8.6 Medtronic
  • 8.7 Novartis (Alcon)
  • 8.8 pSivida Corp.
  • 8.9 Teleflex Incorporated
  • 8.10 3M's Health Care

List Not Exhaustive

9. Future of the Implantable Drug Delivery Devices Market

Back to Top